Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Raymond Sawaya, MD, discusses the addition of patients with brain metastases to clinical trials

Dr. Sawaya, Chairman, Department of Neurosurgery, University of Texas MD Anderson Cancer Center, discusses cancer patients with brain metastases, who have historically been excluded from clinical trials, how this has changed, and criteria that make brain metastases clinical trials unique.

Tags: Brain (includes Glioblastoma Multiforme, Glioma, Brain Mets)SNO Conference

Published: 24 August 2020

Recent Videos: SNO Conference

video

Matthew Dankner considers how CIRBP pathway might be targetable and the status of the research

Matthew Dankner, MD/PhD student, Research Program in Cancer Metastases, McGill University, considers how the cold-inducible RNA binding protein (CIRBP) pathway ...

video

Matthew Dankner explains how CIRBP was identified as important to invasive cells in brain metastases

Matthew Dankner, MD/PhD student, Research Program in Cancer Metastases, McGill University, explains how Cold-inducible RNA binding protein (CIRBP) was identified ...

video

Matthew Dankner describes a double blinded analysis of 164 brain metastases patients characterized by minimally or highly invasive characteristics

Matthew Dankner, MD/PhD student, Research Program in Cancer Metastases, McGill University, describes a double blinded analysis of 164 brain metastases ...

video

Matthew Dankner describes how the concept of invasive histopathology relates to brain metastases

Matthew Dankner, MD/PhD student, Research Program in Cancer Metastases, McGill University, describes how the concept of invasive histopathology provides an ...

video

David Roberge, MD, examines why individuals may prefer SRS while others may would opt for WBRT

Dr. Roberge, Head of Radiation Oncology, University of Montreal, examines why individuals may prefer stereotactic radiotherapy (SRS) while others may ...

video

David Roberge, MD, discusses how COVID-19 affected enrollment in the CE.7 clinical trial

Dr. Roberge, Head of Radiation Oncology, University of Montreal, discusses how COVID-19 affected enrollment in the CE.7 clinical trial, how ...

video

David Roberge, MD, explains rationale for the design of the CE.7 trial

Dr. Roberge, Head of Radiation Oncology, University of Montreal, explains rationale for the design of the CE.7 trial requiring both ...

video

David Roberge, MD, describes rationale for cross-border CE.7 trial in patients with brain metastases

Dr. Roberge, Head of Radiation Oncology, University of Montreal, describes the rationale for the cross-border CE.7 trial enrolling patients with ...

video

Raymond Sawaya, MD, considers definitive clinical trial outcomes and non-invasive treatment

Dr. Sawaya, Chairman, Department of Neurosurgery, University of Texas MD Anderson Cancer Center, considers the definitive clinical trial outcomes in ...

video

Raymond Sawaya, MD, discusses the addition of patients with brain metastases to clinical trials

Dr. Sawaya, Chairman, Department of Neurosurgery, University of Texas MD Anderson Cancer Center, discusses cancer patients with brain metastases, who ...

Related Videos

video-image

Matthew Dankner considers how CIRBP pathway might be targetable and the status of the research

video-image

Matthew Dankner explains how CIRBP was identified as important to invasive cells in brain metastases

video-image

Matthew Dankner describes a double blinded analysis of 164 brain metastases patients characterized by minimally or highly invasive characteristics

video-image

Matthew Dankner describes how the concept of invasive histopathology relates to brain metastases

video-image

David Roberge, MD, examines why individuals may prefer SRS while others may would opt for WBRT

video-image

David Roberge, MD, discusses how COVID-19 affected enrollment in the CE.7 clinical trial

video-image

David Roberge, MD, explains rationale for the design of the CE.7 trial

video-image

David Roberge, MD, describes rationale for cross-border CE.7 trial in patients with brain metastases

video-image

Raymond Sawaya, MD, considers definitive clinical trial outcomes and non-invasive treatment

video-image

Raymond Sawaya, MD, on treating brain metastases with stereotactic radiotherapy prior to resection

video-image

Raymond Sawaya, MD, identifies non-invasive ways of treating brain metastases and possible outcomes

video-image

Raymond Sawaya, MD, discusses whether it is advisable to obtain brain scans at early stages of care

video-image

Raymond Sawaya, MD, shares the incidence and severity of brain metastases amongst cancer patients

video-image

Nader Sanai, MD, on the role of ribociclib in the management of gliomas